Evidence map›Paper›PMID 41450631›Full record

ArticleJACS Au2025

Chloroalkylation of Unactivated Alkenes via a Cobalt-Mediated Radical Ligand Transfer (RLT) Photoredox Catalysis Platform.

Subrata Patra, Anthony J Fernandes, Besa Kadriu, Dmitry Katayev

Abstract read
In one paragraph

Article in JACS Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Subrata PatraDepartment of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland.
Anthony J FernandesDepartment of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland.ORCID https://orcid.org/0000-0001-8372-7982
Besa KadriuDepartment of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland.
Dmitry KatayevDepartment of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland.ORCID https://orcid.org/0000-0003-0131-1188

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of modular difunctionalization strategies for unsaturated hydrocarbons is of particular interest, as it enables access to complex building blocks in a single step. Although great progress has been recently achieved in this field, difunctionalization of simple, nonconjugated alkenes represents a substantial challenge. Inspired by the radical rebound paradigm found in metalloenzymes, radical ligand transfer (RLT) catalysis has recently emerged as a powerful and broadly applicable strategy for the selective functionalization of alkyl radicals. Here, we present our advancements on the metallaphotoredox platform, which leverages the efficient cooperation between photoredox and cobalt RLT catalysis. A variety of electrophilic, functionalized carbon-centered radicals can be generated and efficiently incorporated into alkene derivatives, while the resulting nucleophilic radicals are further harnessed through homolytic substitution at a cobalt-bound ligand, enabling controlled transfer of a halogen nucleophile. The method accommodates a wide variety of radical precursors and exhibits excellent functional group tolerance, enabling efficient access to chloroalkyl derivatives. An integrated approach combining experimental and density functional theory studies revealed fundamental aspects of cobalt-mediated RLT and provided a plausible explanation for the key roles of the silver carbonate additive.

Indexed as

alkene difunctionalizationcarbon-centered radicalscobalt catalysismetallaphotoredoxradical ligand transfer

Identifiers

PMID41450631
PMCPMC12728606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.